Osteonate 70 Mg 70 mg Tablets
PDF Leaflet Revision Date: 25 July 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of post-menopausal and primary hypogonadal osteoporosis.
Dosage (summary)
One 70 mg tablet once weekly.
Onset of Action / Duration
Onset: 30 mins, Duration: Not specified.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Not established; contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Antacids
- Calcium supplements
- Iron supplements
- Magnesium supplements
Contraindications
- Hypersensitivity to alendronate
- Severe renal impairment
- Gastrointestinal disorders
- Inability to sit upright
- Paediatric use
- Hypocalcaemia
Common side effects
- Abdominal pain
- Dyspepsia
- Dysphagia
- Oesophageal ulcer
- Musculoskeletal pain
Counselling Points
- Take with a full glass of water
- Do not lie down for 30 mins after taking
- Avoid taking at bedtime
- Report any thigh or groin pain
Serious warnings
- Osteonecrosis of the jaw
- Severe oesophageal reactions
- Atypical femur fractures
Important Disclaimer
The Osteonate 70 Mg 70 mg Tablets professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
